On 27 October 2015
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 October 2015 to consider and approve the Unaudited Financial Results of the Company for the quarter ended on September 30, 2015 (Q2).Powered by Capital Market - Live News
